The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects

BACKGROUND: Oral insulin 338 is a novel tablet formulation of a long-acting basal insulin. This randomised, open-label, four-period crossover trial investigated the effect of timing of food intake on the single-dose pharmacokinetic properties of oral insulin 338. METHODS: After an overnight fast, 44...

Descripción completa

Detalles Bibliográficos
Autores principales: Halberg, Inge B., Lyby, Karsten, Wassermann, Karsten, Heise, Tim, Plum-Mörschel, Leona, Zijlstra, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856260/
https://www.ncbi.nlm.nih.gov/pubmed/31093929
http://dx.doi.org/10.1007/s40262-019-00772-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856260/
https://www.ncbi.nlm.nih.gov/pubmed/31093929
http://dx.doi.org/10.1007/s40262-019-00772-2

Ejemplares similares